Beverly Hills Private Wealth LLC Purchases 5,552 Shares of Koninklijke Philips (NYSE:PHG)

Beverly Hills Private Wealth LLC lifted its position in shares of Koninklijke Philips (NYSE:PHG) by 8.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 72,537 shares of the technology company’s stock after acquiring an additional 5,552 shares during the quarter. Beverly Hills Private Wealth LLC’s holdings in Koninklijke Philips were worth $1,837,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Wilmington Savings Fund Society FSB purchased a new stake in Koninklijke Philips in the third quarter worth about $54,000. Farther Finance Advisors LLC lifted its position in shares of Koninklijke Philips by 37.1% in the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after purchasing an additional 582 shares during the period. Whipplewood Advisors LLC bought a new position in shares of Koninklijke Philips during the fourth quarter valued at approximately $55,000. Millstone Evans Group LLC purchased a new position in Koninklijke Philips during the fourth quarter valued at approximately $60,000. Finally, Allworth Financial LP raised its stake in Koninklijke Philips by 24.9% in the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock worth $105,000 after buying an additional 797 shares in the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th. UBS Group raised Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy”.

Koninklijke Philips Stock Performance

Shares of PHG opened at $25.62 on Friday. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The firm has a market cap of $24.08 billion, a PE ratio of -30.50, a P/E/G ratio of 0.82 and a beta of 0.81. Koninklijke Philips has a 12 month low of $21.48 and a 12 month high of $32.91. The stock has a fifty day moving average price of $25.04 and a 200-day moving average price of $26.16.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 EPS for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The business had revenue of $5.38 billion during the quarter, compared to analysts’ expectations of $5.10 billion. Equities research analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently announced an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be given a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio is presently -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.